heme Flashcards
(103 cards)
Fetal erythropoiesis
Fetal Erythropoiesis occurs in : Yolk sac (3-8 weeks) Liver (6 weeks to birth) Spleen (10-28 weeks) Bone marrow (18 weeks to adults)
Young liver synthesizes Blood
Hemoglobin development
Embryonic globins (zeta and epsilon) Fetal hemoglobin (HbF)= a2y2 Adult hemoglobin (HbA2)= a2B2 Adult hemoglobin (HbA2)= a2d2 (rare) HbF has a higher affinity for O2 due to less avid binding of 2-3BPG (2-3 BPG tells hemoglobin to release O2), so having less 2-3BPG makes fetal Hgb hold on to O2 more
At birth Hgb is about 50/50 HbF and HbA
ABO and Rh classification
A group has the Anti B antibody (IgM) to B Ag, has the A antigen on it
B group has the Anti A antibody (IgM)
AB group has no antibodies
O group has both antibodies, and they are in IgM and IgG
Rh classification
+ (has the Ag)
Rh - no Ag, so has Anti D antibody (an IgG) (give moms IgG during and after each pregnancy)
Hemolytic disease of the newborn AKA erythroblastosis fetalis
An Rh - mom with an Rh+ baby
First pregnancy: mom exposed to fetal blood (dutring delivery)-> formation of maternal anti-D IgG. Subsequent pregnancy- antiD IgG crosses the placenta and attacks the Fetal RBCs–> hemolysis in the fetus. Hydrops fetalis, jaundice, kernicterius. Prevent by administrating antiD IgG to Rh - moms during third trimenster and peripartum if fetus turns our +. Prevents maternal anti-D IgG production
ABO hemolytic disease of the newborn- Type O mom type A or B fetus, pre exisiting maternal anti-A or anti B cross IgG antibodies cross placenta–> hemolysis in the fetus. Mild jaundice in the neonate in 24 hours, can occur in the first born, Treatment: phototherapy or exchange transfusion
Hematopoiesis
Multipotent stem cell
Myeloid stem cell: Erythroblasts, megakaryocytes, Granulocytes (Eosinophils, Basophils, Bands->PMNs), Monocytes–> Macrophage
Lymphoid cells–> B cells, T cells (Th cells, T cytotoxic ) NK cells
Neutrophils
Acute inflammatory response cells. Numbers increase in bacterial infections Phagocytic. Multilobed nucleus Specific granules contain leukocyte alk phos, collagenase, lysozyme, and lactoferrin
Azurophilic granules (lysosomes) contain proteinases, acid phosphastase, myeloperoxidase, B- glucurondase
increased bands= CML or bacterial infections
chemotactics: c5a, IL8 LtB4, bacterial products, kallikirein, platelet activating facotr
RBCs
Lifespan 120 days
Source of energy is glucose (90% used in glycolysis, 10% used in HMP shunt)
Membranes contain CL/HCO3- antiporter, which allow RBCs to export HCO3 and transport CO2 from the periphery to the lungs for elimination
Anisocytosis- varying sizes
Poikilocytosis = varying shapes
Blue color= RNA
Thrombocytes
lifespan 8-10 days
When activated by endothelial injury, aggregate with other platelets and interact with fibrinogen to form platelt plug
Contain dense granules (Ca++, ADP, Serotonin, Histamine CASH) and a granules (vWF, Fibrinogen, fibronectin, platelt factor 4)
Approximately 1/2 of platet pool is stored in the spleen
Macrophages
Long life in tissues, differentiate from monocytes
Activated by y-inferon
APCs MHC2
Important cellular component of granulomas
CD14 receptor is what initiates septic shock
Eosinophils
Defend against helminths via MBPs
Bilobed nucleus, Packed with large eosinophilic granules of uniform size
produse histaminases, MBP, eosinophil peroxidase, eosinophil cationic protein
PACCMAN causes of eosinophilia Parasites Asthma Eosinophilic granulomatosis with polyaniitis (churg Strauss syndrome) Chronic adrenal insufficiency Myeloproliferative disorders Allergic processes Neoplasia (hodgkin lymphoma)
Basophils
Mediate allergic reaction
Densely basophilic granuls
CML
Mast cells
Can bind the Fc portion of IgE to membrane
Activated by tissue trauma, C3a and C5a, Surface IgE (cross linking by Ag)
release of histamine, heparin, tryptase, and eosinophil chemotactic factors
Involved in type 1 HS reactions, cromolyn sodium prevents mast cell degranulation, used for asthma prophylaxis
Vancomycin, opioids and radiocontrast dye elicit IgE independent mast cell degranulation
Natural killer cells
important in innate immunity, especially against intracellular pathogens, larger than B and T cells, with distinctive cytoplasmic lytic granules (containing perforin and granzyme) act on target cells to induce apoptosis
Contain CD56, and CD16
B cells
Follicles of lymph nodes, white pulp of spleen, unencapsulated lymphoid tissue
Contain Cd19, Cd20 and CD 21
T cells
CD3
CD28 necessary for T cells (Treg, CD4 and CD8)
Plasma cells
Large amounts of antibody
Clock face chromatin distribution with nucleas off to the side, RER and Golgi for secratory white part next to nucleus
mostly found in the bone marrow
Multiple myeloma is a plasma cell dyscrasia
Primary hemostasis
Formation of a platelet plug (endothelial cells contain in the Wieble Palade bodies- vWF and Pselectin with factor 8) they also contain thromboplastin and tPA and PGI2
- Injury to the endothelium–> transient vasoconstriction via neural stimulation reflex and endothelin (from damaged cell)
- Exposure: vWf binds to exposed collagen
- Adhesion: platlets bind vWF bia Gp1b receptor at site of injury–> platelets undergo confirmational change–> Platelets release ADP(allows for exposure of Gp2b3a), TXA2 ( via COX chemotactic for platelets) and Ca+ (needed for coagulation cascade)
- Activation ADP binding to P2Y12 receptor induces Gp2b/3a expression on platelet surface
- Aggregation: Fibrinogen binds Gp2b3a receptos and links platelets
Pro vs anti aggregation factors
PRO coag: TXA2 (released by platelets), decreased blood flow, increased platelet aggregation
Anti coag: PgI2, NO (from endothelial cell) increased blood flow, decreased platelet aggregation
Temporary plug stop bleeding, unstableunstable and easily dislodged–> coag cascade is secondary
Thrombogenesis
formation of insoluble fibrin mesh
ASA irreversibly inhibits COX 1 and 2, thereby inhibiting TXA2 synthesis (no chemotactic)
Clopidorgrel, prasugrel, ticlodipine inhibit ADP induced expression of Gp2b 3a by irreversible blocking of the P2y12 receptor
Abciximab, Eptifibatide, and tirofiban inhibit Gp2b3a (so no fibrinogen binding, FIB or CIX)
Ristocetin is an assay activates vWF to bind Gp1b, failure of aggregation with ristocetin occurs in vWdisease, and Bernard Soulier syndrome
vWF carries/protects factor 8
Bernard soulier syndrome
deficiency in Gp1b receptor (no VwF ability to bind)
Kinin cascade
Kaikrein activates bradykinin
increases vasodilation, increase permeability, increase in pain
Intrinsic pathway
12-12a, 11-11a, 9-9a
vWF activates 8– 8a
then 10- 10a
C1 esterase inhibits kalikrein and 12 and 11
C1 esterase inhbitiro dificeincy - hereditary angioedema
Extrinsic path
7-7a
Tissue factor activates factor 10
Combined pathway
10- 10a via extrinsic and intrinsic path
5a-2-2a (thrombin)
2a- 1 -1a (fibrinogen)- fibrin monomers stabiliizes fibrin between platelets